SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-04-004878
Filing Date
2004-04-07
Accepted
2004-04-07 17:30:47
Documents
12
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d14016e10vk.htm 10-K 530729
3 PROMISSORY NOTE AND PLEDGE AGREEMENT d14016exv10w33.txt EX-10.33 7587
4 AMENDMENT TO EMPLOYMENT AGREEMENT - DAVID E RIGGS d14016exv10w34.txt EX-10.34 12392
5 TERMINATION LETTER - DORIT ARAD d14016exv10w35.txt EX-10.35 7345
6 TERMINATION LETTER - JOAN GILLETT d14016exv10w36.txt EX-10.36 11556
7 SEPARATION FROM EMPLOYMENT LETTER - ARTHUR BOLLON d14016exv10w37.txt EX-10.37 17180
8 CONSENT OF BDO SEIDMAN, LLP d14016exv23w1.htm EX-23.1 1518
9 CONSENT OF ERNST & YOUNG LLP d14016exv23w2.htm EX-23.2 1576
10 CERTIFICATION OF CEO PURSUANT TO SECTION 302 d14016exv31w1.htm EX-31.1 5179
11 CERTIFICATION OF CFO PURSUANT TO SECTION 302 d14016exv31w2.htm EX-31.2 5133
12 CERTIFICATION OF CEO PURSUANT TO SECTION 906 d14016exv32w1.htm EX-32.1 2399
13 CERTIFICATION OF CFO PURSUANT TO SECTION 906 d14016exv32w2.htm EX-32.2 2351
  Complete submission text file 0000950134-04-004878.txt   608157
Mailing Address 2110 RESEARCH ROW 6TH FLOOR DALLAS TX 75235
Business Address 2110 RESEARCH ROW 6TH FLOOR DALLAS TX 75235 214-358-2000
EXEGENICS INC (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26648 | Film No.: 04723080
SIC: 2834 Pharmaceutical Preparations